SAPPHIRE: A randomized phase II study of mFOLFOX6+panitumumab versus 5-FU/LV + panitumumab after 6 cycles of frontline mFOLFOX6+panitumumab in patients with colorectal cancer.

Nakamura, M; Munemoto, Y; Takahashi, M; Kotaka, M; Kuroda, H; Kato, T; Minagawa, N; Noura, S; Fukunaga, M; Kuramochi, H; Touyama, T; Takahashi, T; Akagi, Y; Satake, H; Kurosawa, S; Miura, T; Mishima, H; Sakamoto, J; Oba, K; Nagata, N

JOURNAL OF CLINICAL ONCOLOGY, 2018; 36 (4):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索